Literature DB >> 15627639

Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients.

Satoru Iwase1, Tadashi Murakami, Yuichiro Saito, Keiichi Nakagawa.   

Abstract

Changes in blood cytokines of 28, consenting, terminally ill cancer patients were studied to determine a relationship between cachexia and changes in cytokine levels. Levels of PTHrP and five types of cytokines considered to be associated with cachexia, TNFalpha, IL-1beta, IL-6, IFNgamma and LIF, were measured during routine blood examination and were compared with clinical findings. With the exception of TNF-alpha, which was detected in one patient, only IL-6 was detected in all 28 patients recruited in this study. Ten patients showed a sharp elevation of IL-6 just before death, following a 40-day period in which IL-6 was continually detected in the blood. In six out of these ten patients, levels of 100 pg/mL or more of IL-6 were detected in the week prior to death. The average period between detection of these levels of IL-6 and death was 2.0 days. Progression of carcinoma is believed to induce a variety of cytokines, which cause loss of appetite, weight loss, tissue wasting, and finally patients may become cachectic. Of the six cytokines studied during this test, only the level of IL-6 was significantly elevated, and this sharp rise occurred approximately one week before patients died. We conclude that IL-6 increases only gradually during the early stages of cachexia but then shows a sudden and steep rise just before death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627639

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  22 in total

Review 1.  Interleukin 6 as a key regulator of muscle mass during cachexia.

Authors:  James A Carson; Kristen A Baltgalvis
Journal:  Exerc Sport Sci Rev       Date:  2010-10       Impact factor: 6.230

2.  The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin-6.

Authors:  Brandon N VanderVeen; Dennis K Fix; Ryan N Montalvo; Brittany R Counts; Ashley J Smuder; E Angela Murphy; Ho-Jin Koh; James A Carson
Journal:  Exp Physiol       Date:  2019-01-15       Impact factor: 2.969

Review 3.  Anorexia in cancer: role of feeding-regulatory peptides.

Authors:  Simona Perboni; Akio Inui
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

4.  Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.

Authors:  Kimbell L Hetzler; Justin P Hardee; Melissa J Puppa; Aditi A Narsale; Shuichi Sato; J Mark Davis; James A Carson
Journal:  Biochim Biophys Acta       Date:  2014-12-30

5.  LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP.

Authors:  Thomas Hochdörfer; Christopher Tiedje; Deborah J Stumpo; Perry J Blackshear; Matthias Gaestel; Michael Huber
Journal:  Cell Signal       Date:  2013-03-14       Impact factor: 4.315

Review 6.  Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.

Authors:  Mark Romanick; Ladora V Thompson; Holly M Brown-Borg
Journal:  Biochim Biophys Acta       Date:  2013-03-20

Review 7.  Cachexia and pancreatic cancer: are there treatment options?

Authors:  Tara C Mueller; Marc A Burmeister; Jeannine Bachmann; Marc E Martignoni
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

8.  Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting.

Authors:  Angie M Y Shum; Theodore Mahendradatta; Ryland J Taylor; Arran B Painter; Melissa M Moore; Maria Tsoli; Timothy C Tan; Stephen J Clarke; Graham R Robertson; Patsie Polly
Journal:  Aging (Albany NY)       Date:  2012-02       Impact factor: 5.682

Review 9.  Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia.

Authors:  Derek T Hall; Jennifer F Ma; Sergio Di Marco; Imed-Eddine Gallouzi
Journal:  Aging (Albany NY)       Date:  2011-08       Impact factor: 5.682

10.  Cancer cachexia and anabolic interventions: a case report.

Authors:  Edgar L Dillon; Gurjot Basra; Astrid M Horstman; Shanon L Casperson; Kathleen M Randolph; William J Durham; Randall J Urban; Concepcion Diaz-Arrastia; Lyuba Levine; Sandra S Hatch; Maurice Willis; Gwyn Richardson; Melinda Sheffield-Moore
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-15       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.